-

Tiamat Sciences | Today Nation News, which uses plant-derived proteins to produce cell meat at low cost

TechnologyTiamat Sciences | Today Nation News, which uses plant-derived...

Cell culture medium is a component of cellular agriculture that produces laboratory-grown meat at low cost. However, the conventional method for producing growth factors or reagents for that purpose is expensive in itself and difficult to mass-produce.

According to media reports, a burger made from laboratory-grown meat costs about $ 50 a piece, but new technology makes it a more reasonable £ 1 by 20303. It is said that it will be lowered to the dollar (about 340 yen).

Tiamat Sciences is one of the biotech startups developing cost-effective biomolecules to replace expensive bioreactors. On November 24, the company announced that it had raised $ 3 million in seed investment led by True Ventures. Social Impact Capital and Cantos participated in this.

France-Emanuel Adil, Founder and CEO of Tiamet Sciences (Image Credit: Tiamet Sciences)

CEO France-Emmanuelle Adil founded the company in 2019 with the aim of producing non-animal proteins by growing its own plant molecules. The approach is to combine biotechnology, vertical farming, and computational design (a computer-based design process) to create a unique recombinant protein.

“Currently, the growth factors used in the medium are expensive. We can significantly reduce costs to the same price as meat,” she told TechCrunch.

Adil estimates that today‘s growth factors cost $ 2 million to produce one gram, but efforts such as Tiamat Sciences have now reduced that cost to a tenth. By 2025, it wants to reduce it to 1/1000 and enable mass production.

A small round was held in July 2021 before the $ 3 million seed round, bringing the company’s total funding to $ 3.4 million. The company, which Adil wants to grow, was headquartered in Belgium, but has now moved to North Carolina in May.

The new funding will be used to build pilot production facilities and develop technology in Durham, North Carolina. The company is already on its way to carbon neutrality.

READ MORE  GauG, a community platform for gamers, raises 40 million yen in seeds, strengthens marketing and development human resources | Today Nation News

As for customers, we haven’t been able to announce it yet, but we are developing the first product for release by the end of the year. That will allow Tiamat to send samples for customers to test, but she believes they will somehow become partners by 2022.

According to Adil, Tiamat’s method can be applied not only to food products but also to regenerative medicine and vaccine production.

“The growth factors can be transferred to other industries with similar processes,” she says. “We will be working hard to expand by the end of 2022. The number of plants can be expanded rapidly, so by that time the number of plants should have reached 100,000. Helping with such expansion. We are currently in talks with a company that is likely to give us. “

According to True Ventures co-founder Phil Black, investing in Tiamat Sciences works well with True Ventures’ plant-based portfolio. With the funds raised first, he proved to many people that the company’s technology was effective, and made a prototype of the product. And in the next big round, we will scale from liters to gallons.

“The cell meat industry will continue, and now people are interested in making it profitable for themselves and making more. There are limited elements. , Taimat’s solution will be a game changer, “Black said.

Related article: Canada-based Future Fields confronts the biggest problems with cultured meat, discovering cheap and humane materials that encourage culture

Image Credit: Tiamat Sciences

[To the original text]

(Sentence: Christine Hall, Translation: Hiroshi Iwatani)

.

Latest news

You might also likeRELATED
Recommended to you